These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15368520)

  • 61. Interferon-gamma is produced by CD8 T cells in response to HLA-A24-restricted hepatitis C virus epitopes after sustained virus loss.
    Kobayashi K; Ishii M; Shiina M; Ueno Y; Kondo Y; Kanno A; Miyazaki Y; Yamamoto T; Kobayashi T; Niitsuma H; Kikumoto Y; Takizawa H; Shimosegawa T
    Clin Exp Immunol; 2005 Jul; 141(1):81-8. PubMed ID: 15958073
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24-positive chronic hepatitis C patients.
    Shiina M; Kobayashi K; Kobayashi T; Kondo Y; Ueno Y; Shimosegawa T
    J Gastroenterol; 2006 Aug; 41(8):758-64. PubMed ID: 16988764
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection.
    Kurokohchi K; Arima K; Nishioka M
    J Hepatol; 2001 Jun; 34(6):930-5. PubMed ID: 11451179
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies.
    Löhr HF; Schmitz D; Arenz M; Weyer S; Gerken G; Meyer zum Büschenfelde KH
    J Hepatol; 1999 Sep; 31(3):407-15. PubMed ID: 10488697
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Influence of interferon alpha on the variation of Tc and Ts cells in the peripheral blood of patients with chronic hepatitis B].
    Zhu C; Luo D; Zeng L; Gao Y; Li S
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):123-5. PubMed ID: 11983132
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Soluble CD40 ligand-activated B cells from patients with chronic hepatitis B virus infection as antigen presenting cells to induce hepatitis B virus specific cytotoxic T lymphocytes.
    Liu Y; Huang R; Xiong Y; Zhao Q; Chen G; Xia J; Wu C
    Biochem Biophys Res Commun; 2014 Jul; 450(1):61-6. PubMed ID: 24866241
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HLA-A2-restricted cytotoxic T lymphocyte activity during interferon beta therapy in patients with chronic hepatitis C.
    Ohira H; Iwasaki M; Takiguchi J; Rai T; Shishido S; Abe K; Takeda J; Tojo J; Sato Y; Kasukawa R
    Fukushima J Med Sci; 2002 Dec; 48(2):75-83. PubMed ID: 12680611
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The responses of HBcAg specific CTL to HBV/C variants].
    Zhou FY; Sui LL; Zhang MX; Luo KX; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2006 Aug; 14(8):624-5. PubMed ID: 16938183
    [No Abstract]   [Full Text] [Related]  

  • 69. Hepatitis B e antigen-negative chronic hepatitis B.
    Hadziyannis SJ; Vassilopoulos D
    Hepatology; 2001 Oct; 34(4 Pt 1):617-24. PubMed ID: 11584355
    [No Abstract]   [Full Text] [Related]  

  • 70. Antiviral treatment with alpha interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B.
    Carotenuto P; van Riel D; Artsen A; Bruijns S; Uytdehaag FG; Laman JD; van Nunen AB; Zondervan PE; De Man RA; Osterhaus AD; Pontesilli O
    Antimicrob Agents Chemother; 2005 Feb; 49(2):590-9. PubMed ID: 15673738
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.
    Boni C; Penna A; Bertoletti A; Lamonaca V; Rapti I; Missale G; Pilli M; Urbani S; Cavalli A; Cerioni S; Panebianco R; Jenkins J; Ferrari C
    J Hepatol; 2003 Oct; 39(4):595-605. PubMed ID: 12971971
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection.
    Li J; Han Y; Jin K; Wan Y; Wang S; Liu B; Liu Y; Lu S; Huang Z
    Virol J; 2011 May; 8():199. PubMed ID: 21535873
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis].
    Ettinger OA; Nikitin IG; Storozhakov GI
    Ter Arkh; 1999; 71(12):69-72. PubMed ID: 10647210
    [No Abstract]   [Full Text] [Related]  

  • 74. [Therapy of viral hepatitis].
    Porst H
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():31-2. PubMed ID: 12467003
    [No Abstract]   [Full Text] [Related]  

  • 75. Analysis of hepatitis C virus-specific CD8+ T-cells with HLA-A*24 tetramers during phlebotomy and interferon therapy for chronic hepatitis C.
    Kaji K; Nakamoto Y; Kaneko S
    Oncol Rep; 2007 Oct; 18(4):993-8. PubMed ID: 17786365
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A longitudinal analysis of cytotoxic T lymphocyte precursor frequencies to the hepatitis B virus in chronically infected patients.
    Sing GK; Ladhams A; Arnold S; Parmar H; Chen X; Cooper J; Butterworth L; Stuart K; D'Arcy D; Cooksley WG
    J Viral Hepat; 2001 Jan; 8(1):19-29. PubMed ID: 11155148
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Detection of glypican-3-specific CTLs in chronic hepatitis and liver cirrhosis.
    Hayashi E; Motomura Y; Shirakawa H; Yoshikawa T; Oba N; Nishinakagawa S; Mizuguchi Y; Kojima T; Nomura K; Nakatsura T
    Oncol Rep; 2009 Jul; 22(1):149-54. PubMed ID: 19513517
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Frequencies and characterization of HBV-specific cytotoxic T lymphocytes in self-limited and chronic hepatitis B viral infection in China.
    Yang X; Hao Y; Liu Z; Chen L; Ding H; Zhao X; Lu M; Yang D
    J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):567-74. PubMed ID: 19821088
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of IFNalpha-2a on Fas expression and apoptosis rate of peripheral blood cytotoxic T cells in patients with hepatitis B.
    Hou W; Liu KZ; Li MW; Wo JE
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):403-5. PubMed ID: 16109525
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: tetramer assay and therapeutic implications.
    Tsai SL; Sheen IS; Chien RN; Chu CM; Huang HC; Chuang YL; Lee TH; Liao SK; Lin CL; Kuo GC; Liaw YF
    J Biomed Sci; 2003; 10(1):120-35. PubMed ID: 12566993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.